Gut microbial ecology

Designing Functional Foods: Measuring and Controlling Food Structure Breakdown and Nutrient Absorption

Volumn , Issue , 2009, Pages 38-67

  Flint, H J ^a   Duncan, S H ^a   Louis, P ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77952536739     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845696603.1.38     Document Type: Chapter

References (158)

1. Ahmed S., Macfarlane G.T., Fite A., Mcbain A.J., Gilbert P., Macfarlane S. Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol 2007, 73:7435-7442.
2. Aminov R.I., Walker A.W., Duncan S.H., Harmsen H.J.M., Welling G.W., Flint H.J. Molecular diversity, cultivation, and improved detection by fluorescent in situ hybidization of a dominant group of human gut bacteria related to Roseburia spp. or Eubacterium rectale. Appl Environ Microbiol 2006, 72:6371-6376.
3. Apalajahti J.H., Kettunen H., Kettunen A., Holben W.E., Nurminen P.H., Rautonen N., Mutanen M. Culture-independent microbial community analysis reveals that inulin in the diet primarily affects previously unknown bacteria in the mouse cecum. Appl Environ Microbiol 2002, 68:4986-4995.
4. Avivi-Green C., Polak-Charcon S., Madar Z., Schwartz B. Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colorectal cancer inhibition. Oncol Res 2000, 12:83-95.
5. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovitch C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci 2004, 101:15718-15723.
6. Bajka B.H., Topping D.L., Cobiac L., Clarke J.M. Butyrylated starch is less susceptible to enzymic hydrolysis and increases large-bowel butyrate more than high-amylose maize starch in the rat. Br J Nutr 2006, 96:276-282.
7. Barcenilla A., Pryde S.E., Martin J.C., Duncan S.H., Stewart C.S., Flint H.J. Phylogenetic relationships of dominant butyrate producing bacteria from the human gut. Appl Environ Microbiol 2000, 66:1654-1661.
8. Barnich N., Darfeuille-Michaud A. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol 2007, 13:5571-5576.
9. Belenguer A., Duncan S.H., Calder A.G., Holtrop G., Louis P., Lobley G.E., Flint H.J. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol 2006, 72:3593-3599.
10. Belenguer A., Duncan S.H., Holtrop G., Anderson S.E., Lobley G.E., Flint H.J. Impact of pH on lactate formation and utilization by human fecal microbial communities. Appl Environ Microbiol 2007, 73:6526-6533.
11. 2 by methane and non-methane-producing human colonic bacterial communities. FEMS Microbiol Ecol 1996, 19:193-202.
12. Bibiloni R., Mangold M., Madsen K.L., Fedorak R.N., Tannock G.W. The bacteriology of biopsies differs between newly diagnosed, untreated, Crohn's disease and ulcerative colitis patients. J Med Microbiol 2006, 55:1141-1149.
13. Bik E.M., Eckburg P.B., Gill S.R., Nelson K.E., Purdom E.A., Francois F., Perez-Perez G., Blaser M.J., Relman D.A. Molecular analysis of the bacterial microbiota in the human stomach. Proc Natl Acad Sci USA 2006, 103:732-737.
14. Blaut M., Clavel T. Metabolic diversity of the intestinal microbiota: implications for health and disease. J Nutr 2007, 137:751S-755S.
15. Blaut M., Collins M.D., Welling G.W., DorÉ J., Van Loo J., De Vos W. Molecular biological methods for studying the gut microbiota: the EU human gut flora project. Br J Nutr 2002, 87:S203-S211.
16. Bourriaud C., Robins R.J., Martin L., Kozlowski F., Tenailleau E., Cherbut C., Michel C. Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident. J Appl Microbiol 2005, 99:201-212.
17. Bown R.L., Gibson J.A., Sladen G.E., Hicks B., Dawson A.M. Effects of lactulose and other laxatives on ileal and colonic pH as measured by radiotelemetry device. Gut 1974, 15:999-1004.
18. Charrier C., Duncan G.J., Reid M.D., Rucklidge G.J., Henderson D., Young P., Russell V.J., Aminov R.I., Flint H.J., Louis P. A novel class of CoA-transferase involved in short-chain fatty acid metabolism in butyrate-producing human colonic bacteria. Microbiology 2006, 152:179-185.
19. Chassard C., Goumy V., Leclerc M., Del Homme C., Bernalier-Donadille A. Characterization of the xylan-degrading microbial community from human faeces. FEMS Microbiol Ecol 2007, 61:121-131.
20. Chatterjee S., Park S., Low K., Kong Y., Pimental M. The degree of breath methane production in IBS correlates with the severity of constipation. Am J Gastroenterol 2007, 102:837-841.
21. Clausen M.R., Bonnen H., Tvede M., Mortensen P.B. Colonic fermentation to short chain fatty acids is decreased in antibiotic-associated diarrhoea. Gastroenterology 1991, 101:1497-1504.
22. 13C]-lactate in the rumen of dairy cattle. Appl Environ Microbiol 1981, 42:649-655.
23. Csordas A. Butyrate, aspirin and colorectal cancer. Eur J Cancer Prevent 1996, 5:221-231.
24. Cummings J.H., Bingham S.A. Dietary fibre, fermentation and large bowel cancer. Cancer Surveys 1987, 6:601-621.
25. Cummings J.H., Pomare E.W., Branch W.J., Naylor C.P.E., Macfarlane G.T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987, 28:1221-1227.
26. Cummings J.H., Beatty E.R., Kingman S.M., Bingham S.A., Englyst H.N. Digestion and physiological properties of resistant starch in the human large bowel. Br J Nutr 1996, 75:733-747.
27. De Graaf A.A., Venema K. Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol 2008, 53:73-168.
28. De La Cochetiere M.F., Durand T., Kepage P., Boureille A., Galmiche J.P., Dore J. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 2005, 43:5588-5592.
29. 4]tyrosine to assess the effects of pro- and prebiotics on the intestinal flora of healthy human volunteers. Br J Nutr 2004, 92:439-446.
30. De Schrijver R., Vanhoof K., Vande Ginste J. Effect of enzyme resistant starch on large bowel fermentation in rats and pigs. J Nutr 1999, 19:927-936.
31. Den Hond E., Hiele M., Evenepoel P., Peeters M., Ghoos Y., Rutgeerts P. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Gastroenterology 1998, 115:584-590.
32. Denman S.E., Tomkins N.W., Mcsweeney C.S. Quantification and diversity analysis of ruminal methanogenic populations in response to the antimethanogenic compound bromochloromethane. FEMS Microbiol Ecol 2007, 62:313-322.
33. Deplancke B., Hristova K.R., Oakley H.A., Mccracken V.J., Aminov R., Mackie R.I., Gaskins H.R. Molecular ecological analysis of the succession and diversity of sulfate-reducing bacteria in the mouse gastrointestinal tract. Appl Environ Microbiol 2000, 66:2166-2174.
34. Dethlefsen L.M., Eckburg P.B., Bik E.M., Relman D.A. Assembly of the human intestinal microbiota. Trends Ecol Evol 2006, 21:517-523.
35. 2-utilizing archaea, acetogenic and sulfate-reducing bacteria from human feces. FEMS Microbiol Ecol 1995, 17:279-284.
36. Drzikova B., Dongowski G., Gebardt E. Dietary fibre-rich oat-based products affect serum lipids, microbiota, formation of short-chain fatty acids and steroids in rats. Br J Nutr 2005, 94:1012-1025.
37. Dumas M.-E., Barton R.H., Cloarec O., Blancher C., Rothwell A., Fearnside J., Tatoud R., Blanc V., Lindon J.C., Mitchell S.C., Holmes E., Mccarthy M.I., Scott J., Gaughier D., Nicholson J.K. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA 2006, 103:12511-12516.
38. Dumont M.G., Murrell J.C. Stable isotope probing - linking microbial identity to function. Nature Rev Microbiol 2005, 3:499-504.
39. Duncan S.H., Barcenilla A., Stewart C.S., Pryde S.E., Flint H.J. Acetate utilization and butyryl coenzyme A (CoA): acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol 2002, 68:5186-5190.
40. Duncan S.H., Holtrop G., Lobley G.E., Calder A.G., Stewart C.S., Flint H.J. Contribution of acetate to butyrate formation by human faecal bacteria. Br J Nutr 2004, 91:915-923.
41. Duncan S.H., Louis P., Flint H.J. Lactate-utilising bacteria, isolated from human faeces, that produce butyrate as a major fermentation product. Appl Environ Microbiol 2004, 70:5810-5817.
42. Duncan S.H., Aminov R.I., Scott K.P., Louis P., Stanton T.B., Flint H.J. Proposal of Roseburia faecis (sp. nov.), Roseburia hominis (sp. nov.), and Roseburia inulinivorans (sp. nov.), based on isolates from human faeces. Int J Syst Evol Microbiol 2006, 56:2437-2441.
43. Duncan S.H., Belenguer A., Holtrop G., Johnstone A.M., Flint H.J., Lobley G.E. Reduced dietary intake of carbohydrate, by obese subjects, results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Micobiol 2007, 73:1073-1078.
44. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
45. Egert M., De Graaf A.A., Maathuis A., De Waard P., Plugge C.M., Smidt H., Deutz N.E., Dijkema C., De Vos W.M., Venema K. Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol Ecol 2007, 60:126-135.
46. El Oufir L., Barry J.L., FlouriÉ B., Cherbut C., Cloarec D., Bornet F., Galmiche J.P. Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria. Eur J Clin Nutr 2000, 54:603-609.
47. Englyst K.N., Liu S., Englyst H.N. Nutritional characterization and measurement of dietary carbohydrates. Eur J Clin Nutr 2007, 61:S19-S39.
48. Fallinborg J., Christensen L.A., Jacobsen B.A., Rasmussen S.N. Very low intraluminal colonic pH in patients with ulcerative colitis. Dig Dis Sci 1993, 38:1989-1993.
49. Falony G., Viachou A., Verbrugge K., De Vuyst L. Cross-feeding between Bifidobacterium longum BB536 and acetate converting, butyrate-producing colon bacteria during growth on oligofructose. Appl Env Microbiol 2006, 72:7835-7841.
50. Fite A., Macfarlane G.T., Cummings J.H., Hopkins M.J., Kong S.C., Furrie E., Macfarlane S. Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction. Gut 2004, 53:523-529.
51. Fleming S.E., Choi Y.S., Fitch D.M. Absorption of short chain fatty acids from the rat caecum in vivo. J Nutr 1991, 121:1787-1789.
52. Flint H.J., Leitch E.C.M., Duncan S.H., Walker A.W., Patterson A., Rincon M.T., Scott K.P., Louis P. Avian Gut Function in Health and Disease. Molecular approaches to the analysis of gastrointestinal microbial ecosystems 2006, 107-123. CAB International, Wallingford. G. Perry (Ed.).
53. Flint H.J., Duncan S.H., Scott K.P., Louis P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol 2007, 9:1101-1111.
54. Flint H.J., Bayer E.A., Rincon M.T., Lamed R., White B.A. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nature Rev Microbiol 2008, 6:121-131.
55. Floch M.H. Bile salts, intestinal microflora and enterohepatic circulation. Digest Liver Dis 2002, 34:S54-S57.
56. Florin T.H.F., Zhu G., Kirk K.M., Martin N.G. Shared and unique environmental factors determine the ecology of methanogens in human and rats. Am J Gastroenterol 2000, 95:2872-2879.
57. Folino M., Mcintyre A., Young G.P. Dietary-fibers differ in their effects on large-bowel epithelial proliferation and faecal fermentation-dependent events in rats. J Nutr 1995, 125:1521-1528.
58. Foxx-Orenstein A. IBS - review and what's new. Med Gen Med 2006, 8:20.
59. Frank D.N., Pace N.R. Molecular-phylogenetic analyses of human gastrointestinal microbiota. Curr Opin Gastroenterol 2001, 17:52-57.
60. Frank D.N., Pace N.R. Gastrointestinal microbiology enters the metagenomic era. Curr Op Gastroenterol 2008, 24:4-10.
61. Franks A.H., Harmsen H.J.M., Raangs G.C., Jansen G.J., Schut F., Welling G.W. Variations of bacterial populations in human feces measured by fluorescent in situ hybridisation with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998, 64:3336-3345.
62. Gaudier E., Jarry A., Blottiere H.M., De Coppet P., Buisine M.P., Aubert J.P., Laboisse C., Cherbut C., Hoebler C. Butyrate specifically modulates MUC gene expression in intestinal epithelial cells deprived of glucose. Am J Physiol Gastrointest Liver physiol 2004, 287:G1168-G1174.
63. Gibson G.R., Cummings J.H., Macfarlane G.T. Competition for hydrogen between sulphate-reducing bacteria and methanogenic bacteria from the human large intestine. J Appl Bacteriol 1988, 65:241-247.
64. Gill C.I.R., Rowland I.R. Diet and cancer: assessing the risk. Br J Nutr 2002, 88(1):S73-87.
65. Gill S.R., Pop M., Deboy R.T., Eckburg P.B., Turnbaugh P.J., Samuel B.S., Gordon J.I., Relman D.A., Fraser-Liggett C.M., Nelson K.E. Metagenomic analysis of the human distal gut microbiome. Science 2006, 312:1355-1359.
66. Gloux K., Leclerc M., Iliozer H., LHaridon R., Manichanh C., Corthier G., Nalin R., BlottiÈRe H.M., DorÉ J. Development of high-throughput phenotyping of metagenomic clones from the human gut microbiome for modulation of Eukaryotic cell growth. Appl Environ Microbiol 2007, 73:3734-3737.
67. Goldenberg O., Herrmann S., Marjoram G., Noyer-Weidner M., Hong G., Bereswill S., GÖBel U.B. Molecular monitoring of the intestinal flora by denaturing high performance liquid chromatography. J Microbiol Meth 2007, 68:94-105.
68. Gupta N., Martin P.M., Prasad P.D., Ganapathy V. SLC5A8 (SMCT-1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter. Life Sci 2006, 78:2419-2425.
69. Hamer H.M., Jonkers D., Venema K., Vanhoutvin S., Troost F.J., Brummer R.J. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008, 27:104-119.
70. Hayashi H., Sakamoto M., Benno Y. Phylogenetic analysis of the human gut mircobiota using 16S rDNA clone libraries and strictly anaerobic culture methods. Microbiol Immunol 2002, 46:535-548.
71. Hinnebusch B.F., Meng S.F., Wu J.T., Archer S.Y., Hodin R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J Nutr 2002, 132:1012-1017.
72. Hold G.L., Pryde S.E., Russell V.J., Furrie E., Flint H.J. Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 2002, 39:33-39.
73. Hope M.E., Hold G.L., Kain R., El-Omar E.M. Sporadic colorectal cancer-role of the commensal microbiota. FEMS Microbiol Lett 2005, 244:1-7.
74. Hove H., Norgard Andersen I., Mortensen P.B. Fecal DL-lactate concentrations in 100 gastrointestinal patients. Scand J Gastroenterol 1994, 29:255-259.
75. Huycke M.M., Gaskins H.R. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med 2004, 229:586-597.
76. Jacobs D.M., Deltimple N., Van Velzen E., Van Dorsten F.A., Bingham M., Vaughan E.E., Van Duynhoven J. 1H NMR metabolite profiling of feces as a tool to assess the impact of nutrition on the human microbiome. NMR Biomed 2008, 21:615-626.
77. Jones B.V., Sun F., Marchesi J.R. Using skimmed milk agar to functionally screen a gut metagenomic library for proteases may lead to false positives. Lett Appl Microbiol 2007, 45:418-420.
78. Kanauchi O., Fujiyama Y., Mitsuyama K., Araki Y., Ishii T., Nakamura T., Hitomi Y., Agata K., Saiki T., Andoh A., Toyonaga A., Bamba T. Increased growth of Bifidobacterium and Eubacteriumby germinated barley foodstuff, accompanied by enhanced butyrate production in healthy volunteers. Int J Mol Med 1999, 3:175-179.
79. King T.S., Elia M., Hunter J.O. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998, 352:1187-1189.
80. Kruse H.-P., Kleessen B., Blaut M. Effects of inulin on faecal bifidobacteria in human subjects. Br J Nutr 1999, 82:375-382.
81. Kurokawa K., Itoh T., Kuwahara T., Oshima K., Toh H., Toyoda A., Takami H., Morita H., Sharma V.K., Srivastava T.P., Taylor T.D., Noguchi H., Mori H., Ogura Y., Ehrlich D.S., Itoh K., Takagi T., Sakaki Y., Hayashi T., Hattori M. Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 2007, 14:169-181.
82. Lambert D.W., Wood I.S., Ellis A., Shirazi-Beechey S.P. Molecular changes in the expression of human colonic nutrient transporters during transition from normality to malignancy. Br J Cancer 2002, 86:1262-1269.
83. Leitch E.C., Walker A.W., Duncan S.H., Holtrop G., Flint H.J. Selective colonisation of insoluble substrates by human faecal bacteria. Environ Microbiol 2007, 72:667-679.
84. Lewis S.J., Heaton K.W. Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 1997, 41:245-251.
85. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology - human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
86. Li M., Wang B., Zhang M., Rantalainen M., Wang S., Zhou H., Zhang Y., Shen J., Pang X., Zhang M., Wei H., Chen Y., Lu J., Su M., Qiu Y., Jia W., Xiao C., Smith L.M., Yang S., Holmes E., Tang H., Zhao G., Nicholson J.K., Li L., Zhao L. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008, 105:2117-2122.
87. Louis P., Flint H.J. Development of a semiquantitative degenerate real-time PCR-based assay for estimation of numbers of butyryl-Coenzyme A (CoA) CoA transferase genes in complex bacterial samples. Appl Environ Microbiol 2007, 73:2009-2012.
88. Louis P., Duncan S.H., Mccrae S., Millar J., Jackson M.S., Flint H.J. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol 2004, 186:2099-2106.
89. Macfarlane G.T., Englyst H.N. Starch utilization by the human large intestinal microflora. J Appl Bacteriol 1986, 60:195-201.
90. Macfarlane G.T., Gibson G.R. Gastrointestinal Microbiology. Carbohydrate fermentation, energy transduction and gas metabolism in the human large intestine 1997, 269-318. Chapman and Hall, London. R.I. Mackie, B.A. White (Eds.).
91. Macfarlane G.T., Gibson G.R., Cummings J.H. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992, 72:57-64.
92. Manach C., Scalbert A., Morand C., Remesy C., Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004, 79:727-747.
93. Manichanh C., Rigottier-Gois L., Bonnaud E., Gloux K., Pelletier E., Frangeul L., Nalin R., Jarrin C., Chardon P., Marteau P., Roca J., Dore J. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2007, 55:205-211.
94. Marchesi J.R., Holmes E., Khan F., Kochhar S., Scanlan P., Shanahan F., Wilson I.D., Wang Y. Rapid and non-invasive metabonomic characterization of inflammatory bowel disease. J Proteome Res 2007, 6:546-551.
95. Martin F.-P.J., Dumas M.-E., Wang Y., Legido-Quigley C., Yap I.K.S., Tang H., Zirah S., Murphy G.M., Cloarec O., Lindon J.C., Sprenger N., Fay L.B., Kochhar S., Van Bladeren P., Holmes Nicholson J.K. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol 2007, 3:112.
96. Matsuki T., Watanabe K., Fujimoto J., Miyamoto Y., Takada T., Matsumoto K., Oyaizu H., Tanaka R. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002, 68:5445-5451.
97. Mcintyre A., Gibson P.R., Young G.P. Butyrate production from dietary fiber and protection against large bowel cancer in a rat model. Gut 1993, 34:386-391.
98. Mcneil N.I. The contribution of the large intestine to energy supplies in man. Am J Clin Nutr 1984, 39:338-342.
99. Miller T.L., Wolin M.J. Pathways of acetate, propionate and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 1996, 62:1589-1592.
100. Morrison D.J., Mackay W.G., Edwards C.A., Preston T., Dodson B., Weaver L.T. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate. Brit J Nutr 2006, 96:570-577.
101. Muir J.G., Yeow E.G.W., Keogh J., Pizzey C., Bird A.R., Sharpe K., ODea K., Macrae F.A. Combining wheat bran with resistant starch has more beneficial effects on fecal indices than does wheat bran alone. Am J Clin Nutr 2004, 79:1020-1028.
102. Nagashima K., Hisada T., Sato M., Mochizuki J. Application of new primer-enzyme combinations to terminal restriction fragment length polymorphism profiling of bacterial populations in human feces. Appl Environ Microbiol 2003, 69:1251-1262.
103. Neufeld J.D., Wagner M., Murrell J.C. Who eats what, where and when? Isotope-labelling experiments are coming of age. ISME J 2007, 1:103-110.
104. Nicholson J.K., Wilson I.D. Understanding "global" systems biology: metabonomics and the continuum of metabolism. Nature Rev Drug Discov 2003, 2:668-676.
105. Nicholson J.K., Holmes E., Wilson I.D. Gut microorganisms, mammalian metabolism and personalized health care. Nauret Rev Microbiol 2005, 3:431-438.
106. Nugent A.P. Health properties of resistant starch. Brit Nutr Foundation Bull 2005, 30:27-54.
107. OKeefe S.J.D. Nutrition and colonic health: the critical role of the microbiota. Curr Opin Gastroenterol 2008, 24:51-58.
108. Ordovas J.M., Mooser V. Metagenomics: the role of the microbiome in cardiovascular diseases. Curr Opin Lipidol 2006, 17:157-161.
109. Palmer C., Bik E.M., Eisen M.B., Eckburg P.B., Sana T.R., Wolber P.K., Relman D.A., Brown P.O. Rapid quantitative profiling of complex microbial populations. Nucl Acids Res 2006, 34:e5.
110. Picton R., Eggo M.C., Langman M.J.S., Singh S. Impaired detoxification of hydrogen sulfide in ulcerative colitis?. Dig Dis Sci 2007, 52:373-378.
111. Pimentel M., Lin H.C., Enayati P., Van Den Burg B. Methane, a gas produced by enteric bacteria slows intestinal transit and augments small intestinal contractile activity. Am J Physiol 2006, 290:G1089-1095.
112. Pryde S.E., Duncan S.H., Hold G.L., Stewart C.S., Flint H.J. The microbiology of butyrate formation in the human colon. FEMS Microbiol Letts 2002, 217:133-139.
113. Queenan K.M., Stewart M.L., Smith K.N., Thomas W., Fulcher R.G., Slavin J.L. Concentrated oat -glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial. Nutr J 2007, http://www.nutritionj.com/content/6/1/6.
114. Quigley E.M.M. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. J Dig Dis 2007, 8:2-7.
115. Ramsay A.G., Scott K.P., Martin J.C., Rincon M.T., Flint H.J. Cell associated -amylases of butyrate-producing Firmicute bacteria from the human colon. Microbiology 2006, 152:3281-3290.
116. Riboli E., Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003, 78:559S-569S.
117. Riesenfeld C.S., Schloss P.D., Handelsman J. Metagenomics: genomic analysis of microbial communities. Annu Rev Genet 2004, 28:525-552.
118. Rigottier-Gois L., Le Bourhis A.G., Gramet G., Rochet V., DorÉ J. Fluorescent hybridisation combined with flow cytometry and hybridisation of total RNA to analyse the composition of microbial communities in human faeces using 16S rRNA probes. FEMS Microbiol Ecol 2003, 43:237-245.
119. RinttilÄ T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 2004, 97:1166-1177.
120. Ritzhaupt A., Ellis A., Hosie K.P., Shirazi-Beechey S.P. The characterisation of butyrate transport across pig and human colonic luminal membrane. J Physiol 1998, 507:819-830.
121. Roediger W.E.W. The colonic epithelium in ulcerative colitis - an energy deficiency disease. Lancet 1980, 2:712-715.
122. Roediger W.E.W., Moore J., Babidge W. Colonic sulphide in pathogenesis and treatment of ulcerative colitis. Dig Dis Science 1997, 42:1571-1579.
123. Rosignoli P., Fabiani R., De Bartolomeo A., Spinozzi F., Agea E., Pelli M.A., Morozzi G. Protective activity of butyrate on hydrogen peroxide induce DNA damage in isolated human colonocytes and HT29 tumour cells. Carcinogenesis 2001, 22:1675-1680.
124. Rossi M., Corradini C., Amaretti A., Nicolini M., Pompei A., Zanoni S., Matteuzzi D. Fermentation of fructooligosaccharides and inulin by bifidobacteria: a comparative study of pure and faecal cultures. Appl Environ Microbiol 2005, 71:6150-6158.
125. Russell W.R., Labat A., Scobbie L., Duncan S.H. Availability of blueberry phenolics for microbial metabolism in the colon and the potential inflammatory implications. Mol Nut Food Res 2006, 51:726-731.
126. Salyers A.A., Vercelotti J.R., West S.E.H., Wilkins T.D. Fermentation of mucin and plant polysaccharides by strains of Bacteroides from the human colon. Appl Environ Microbiol 1977, 33:319-322.
127. Salyers A.A., West S.E.H., Vercellotti J.R., Wilkins T.D. Fermentation of mucins and plant polysaccharides by anaerobic bacteria from the human colon. Appl Environ Microbiol 1977, 34:529-533.
128. Scanlan P.D., Shanahan F., Clune Y., Collins J.K., OSullivan G.C., ORiordan M., Holmes E., Wang Y., Marchesi J.R. Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Env Microbiol 2008, 10:789-798.
129. Scheppach W. Effects of short chain fatty acids on gut morphology and function. Gut 1994, 35(1):S35-S38.
130. Scheppach W., Pomare E.W., Elia M., Cummings J.H. The contribution of the large intestine to blood acetate in man. Clin Sci 1991, 80:177-182.
131. Scheppach W., Sommer H., Kirchner T., Paganelli G.M., Bartram P., Richter F., Dusel G., Kasper H. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992, 103:51-56.
132. Scott K.P., Martin J.C., Campbell G., Mayer C.-D., Flint H.J. Whole-genome transcription profiling reveals genes up-regulated by growth on fucose in the human gut bacterium Roseburia inulinivorans. J Bacteriol 2006, 188:4340-4349.
133. Seksik P., Sokol H., Lepage P., Vasquez N., Manichanh C., Mangin I., Pochart P., DorÉ J., Marteau P. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther 2006, 24(3):11-18.
134. Sonnenburg E.D., Xu J., Leip D.D., Chen C.H., Westover B.P., Weatherford J., Buhler J.D., Gordon J.I. Glycan foraging in vivo by an intestine-adapted bacterial symbiont. Science 2005, 307:1955-1959.
135. Stephen A.M., Wiggins H.S., Cummings J.H. Effect of changing transit time on colonic microbial metabolism in man. Gut 1987, 28:601-609.
136. Strober W., Fuss I., Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007, 117:514-521.
137. Suau A., Bonnet R., Sutren M., Godon J.J., Gibson G.R., Collins M.D., Dore J. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 1999, 65:4799-4807.
138. Swidsinski A., Loening-Baucke V., Vaneechoutte M., Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008, 14:147-161.
139. Tannock G.W., Munro K., Bibiloni R., Simon M.A., Hargreaves P., Gopal P., Harmsen H., Welling G. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl Environ Microbiol 2004, 70:2129-2136.
140. Toden S., Bird A.R., Topping D.L., Conlon M.A. Dose-dependent reduction of dietary protein-induced colonocyte DNA damage by resistant starch in rats correlates more highly with caecal butyrate than with other short chain fatty acids. Cancer Biol Ther 2007, 6:253-258.
141. Topping D.I., Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001, 81:1031-1064.
142. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
143. Turnbaugh P.J., Ley R.E., Hamady M., Fraser-Liggett C.M., Knight R., Gordon J.I. The human microbiome project. Nature 2007, 499:804-810.
144. Uchiyama T., Watanabe K. The SIGEX scheme: high throughput screening of environmental metagenomes for the isolation of novel catabolic genes. Biotechnol Genet Eng Rev 2007, 24:107-116.
145. Vernia P., Caprilli R., Latella G., Barbetti F., Magliocca F.M., Cittadini M. Fecal lactate and ulcerative colitis. Gastroenterology 1988, 95:1564-1568.
146. Von Wintzingerode F., GÖBel U.B., Stackebrandt E. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev 1997, 21:213-229.
147. Wagner M., Smidt H., Loy A., Zhou J. Unravelling microbial communities with DNA-microarrays: challenges and future directions. Microb Ecol 2007, 53:498-506.
148. Walker A.W., Duncan S.H., Leitch E.C.M., Child M.W., Flint H.J. pH and peptide supply can radically alter bacterial populations and short chain fatty acid ratios within microbial communities from the human colon. Appl Environ Microbiol 2005, 71:3692-3700.
149. Walker A.W., Duncan S.H., Harmsen H.J.M., Holtrop G., Welling G.W., Flint H.J. The species composition of the human intestinal microbiota differs between fibre-associated and liquid phase communities. Environ Microbiol 2008, 10:3275-3283.
150. Wang M., AhrnÉ S., Jeppsson B., Molin G. Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 2005, 54:219-231.
151. Wang R.F., Beggs M.L., Erickson B.D., Cerniglia C.E. DNA microarray analysis of predominant human intestinal bacteria in fecal samples. Mol Cell Probes 2004, 18:223-234.
152. Windmueller H.G., Spaeth A.E. Identification of ketone bodies and glutamine as major respiratory fuels in vivo for post absorptive rat small intestine. J Biol Chem 1978, 253:69-76.
153. Wolever T.M., Spadafora P.J., Cunnane S.C., Pencharz P.B. Propionate inhibits incorporation of colonic 1,2-13C] acetate into plasma lipids in humans. Am J Clin Nutr 1995, 53:681-687.
154. Wolin M.J., Miller T.L., Yerry S., Zhang Y., Bank S., Weaver G.A. Changes of fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon. Appl Environ Microbiol 1999, 65:2807-2812.
155. Wood J., Scott K.P., Avgustin G., Newbold C.J., Flint H.J. Estimation of the relative abundance of different Bacteroides and Prevotella ribotypes in gut samples by restriction enzyme profiling of PCR-amplified 16S rRNA gene sequence. Appl Environ Microbiol 1998, 64:3683-3689.
156. Xu J., Bjursell M.K., Himrod J., Deng S., Carmichael L.K., Chiang H.C., Hooper L.V., Gordon J.I. A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076.
157. Yu Z., Yu M., Morrison M. Improved serial analysis of V1 ribosomal sequence tags (SARST-V1) provides a rapid, comprehensive, sequence-based characterization of bacterial diversity and community composition. Environ Microbiol 2006, 8:603-611.
158. Zoetendal E.G., Akkermans A.D.L., De Vos W.M. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998, 64:3854-3859.